CoChat

A novel strategy to identify candidate diagnostic and prognostic biomarkers for gastric cancer

Open access
Liu, Lei, Pang, Honglin, He, Qiao, Pan, Biran, Sun, Xiaobin, Shan, Jing, Wu, Liping, Wu, Kaiwen, Yao, Xue, Guo, Yuanbiao · 2021 · Cancer Cell International

The DOI matches its Crossref record; the references it cites are not checked yet.

Abstract

Background: Gastric cancer (GC) is one of the most common cancer worldwide. It is essential to identify non-invasive diagnostic and prognostic biomarkers of GC. The aim of the present study was to screen candidate biomarkers associated with the pathogenesis and prognosis of GC by a novel strategy. Methods: The expression level of gene higher in cancer than in adjacent non-cancer tissue was defined as “positive”, and the top 5% genes with “positive rate” were filtered out as candidate diagnostic biomarkers in three Gene Expression Omnibus (GEO) datasets. Further, a prognostic risk model was constructed by multivariate Cox regression analysis in GEO dataset and validated in The Cancer Genome Atlas (TCGA). The expression level of candidate biomarkers was determined in serum and serum-derived exosomes of GC patients. Moreover, the effect of biomarkers in exosomes on migration of GC cells was analyzed by transwell assay. Results: Ten candidate biomarkers (AGT, SERPINH1, WNT2, LIPG, PLAU, COL1A1, MMP7, MXRA5, CXCL1 and COL11A1) were identified with efficient diagnostic value in GC. A prognostic gene signature consisted of AGT, SERPINH1 and MMP7 was constructed and showed a good performance in predicting overall survivals in TCGA. Consistently, serum levels of the three biomarkers also showed high sensitivity and specificity in distinguishing GC patients from controls. In addition, the expression level of the three biomarkers were associated with malignant degree and decreased after surgery in GC patients. Moreover, the expression level of AGT and MMP7 in exosomes correlated positively with serum level. The exosomes derived from serum of GC patients can promote migration of SGC‐7901 cells. After neutralized the expression level of three proteins in exosomes with antibodies, the migration of GC cells was obviously suppressed. Conclusions: Our findings provided a novel strategy to identify diagnostic biomarkers based on public datasets, and suggested that the three-gene signature was a candidate diagnostic and prognostic biomarker for patients with GC.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1186/s12935-021-02007-6

Cites

Statistics

Figures

Fig. 1 Flowchart for the novel strategy to identify candidate diagnostic and prognostic biomarkers in GC. TCGA, The Cancer Genome Atlas; ROC, receiver operating characteristic
Fig. 1 Flowchart for the novel strategy to identify candidate diagnostic and prognostic biomarkers in GC. TCGA, The Cancer Genome Atlas; ROC, receiver operating characteristicCC BY · PubMed Central
Fig. 2 Venn diagram of the top 5% of positive rates genes among the three training GEO datasets
Fig. 2 Venn diagram of the top 5% of positive rates genes among the three training GEO datasetsCC BY · PubMed Central
Fig. 3 Kaplan–Meier estimates of the survival for patients using the three-gene signature. A, F Three-gene signature risk score distribution in the training and validation datasets. The black dotted line represents the median three-gene signature risk score cutoff dividing patients into low-risk and high-risk groups. B, G GC patients’ survival status in the training and validation datasets. C, H Heatmap of the three gene expression profiles in the training and validation datasets. Rows represent genes, and columns represent patients. Red: high expression; Blue: low expression. D, I Kaplan–Meier analysis for the overall survival of GC patients in the training and validation datasets. E, J The ROC curves for predicting OS in GC patients by the three-gene signature risk score
Fig. 3 Kaplan–Meier estimates of the survival for patients using the three-gene signature. A, F Three-gene signature risk score distribution in the training and validation datasets. The black dotted line represents the median three-gene signature risk score cutoff dividing patients into low-risk and high-risk groups. B, G GC patients’ survival status in the training and validation datasets. C, H Heatmap of the three gene expression profiles in the training and validation datasets. Rows represent genes, and columns represent patients. Red: high expression; Blue: low expression. D, I Kaplan–Meier analysis for the overall survival of GC patients in the training and validation datasets. E, J The ROC curves for predicting OS in GC patients by the three-gene signature risk scoreCC BY · PubMed Central
Fig. 4 The potential diagnostic value of serum level of three candidate biomarkers in GC patients. (A-C) The expression levels of three candidate biomarkers in serum from NC and GC patients. (D-G) The potential diagnostic value of serum level of three candidate biomarkers in GC patients by ROC curve analysis. ***P < 0.001, ****P < 0.0001
Fig. 4 The potential diagnostic value of serum level of three candidate biomarkers in GC patients. (A-C) The expression levels of three candidate biomarkers in serum from NC and GC patients. (D-G) The potential diagnostic value of serum level of three candidate biomarkers in GC patients by ROC curve analysis. ***P < 0.001, ****P < 0.0001CC BY · PubMed Central
Fig. 5 Changes of serum level of three candidate biomarkers in GC patients undergoing surgery. *P < 0.05
Fig. 5 Changes of serum level of three candidate biomarkers in GC patients undergoing surgery. *P < 0.05CC BY · PubMed Central
Fig. 6 The correlation of the expression levels of three candidate biomarkers between serum and exosomes. A–C The exosomes which isolated by ExoQuick precipitation were identified by NTA, Western blotting and TEM. The black arrows indicate impurities. D The expression levels of three candidate biomarkers between serum and exosomes
Fig. 6 The correlation of the expression levels of three candidate biomarkers between serum and exosomes. A–C The exosomes which isolated by ExoQuick precipitation were identified by NTA, Western blotting and TEM. The black arrows indicate impurities. D The expression levels of three candidate biomarkers between serum and exosomesCC BY · PubMed Central
Fig. 7 The expression level of three proteins in exosomes derived from NC and GC patients. A–D The concentration and purity of exosomes which isolated by SEC were determined by NTA, BCA, Western blotting and TEM. E The uptake of DiI-labeled exosomes derived from serum of GC patients by SGC7901. Nuclei were counterstained with DAPI. F The migration of SGC7901 treated with neutralized exosomes by antibodies. *P < 0.05, **P < 0.01
Fig. 7 The expression level of three proteins in exosomes derived from NC and GC patients. A–D The concentration and purity of exosomes which isolated by SEC were determined by NTA, BCA, Western blotting and TEM. E The uptake of DiI-labeled exosomes derived from serum of GC patients by SGC7901. Nuclei were counterstained with DAPI. F The migration of SGC7901 treated with neutralized exosomes by antibodies. *P < 0.05, **P < 0.01CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

The citation lists are queued

They are fetched later and appear here then.

References 35 · Cited by 29

Research works printed but not linked: 1

  1. Tatsuta M, Itoh T, Okuda S, Yamamura H, Baba M, Tamura H. Carcinoembryonic antigen in gastric juice as an aid in diagnosis of early gastric cancer. Cancer. 1980;46(12):2686–92. · doi:10.1002/1097-0142(19801215)46:12<2686::aid-cncr2820461225>3.0.co;2-e

Metadata

Authors
Liu, L., Pang, H., He, Q., Pan, B., Sun, X., Shan, J., Wu, L., Wu, K., Yao, X., & Guo, Y.
Affiliations
  • Third People's Hospital of Chengdu (CN)
  • Southwest Jiaotong University (CN)
  • University of Electronic Science and Technology of China (CN)
  • Qinzhou Maternity and Child Health Care Hospital (CN)
Corresponding author
  • Liu, Lei
  • Guo, Yuanbiao
Venue
Cancer Cell International
Published
2021-07-02
Volume
21
Issue
1
Pages
335-335
ISSN
1475-2867 (ISSN-L)
OpenAlex
W3175971135
Cited by
29
References
35
Citations by year
2026: 3 · 2025: 3 · 2024: 9 · 2023: 9 · 2022: 3 · 2021: 1
FWCI
3.73
Type
journal article
Language
en
Open access
Licence
Locations
  • Cancer Cell International (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Funders
  • Department of Science and Technology of Sichuan Province (2020YFS0492)
  • Applied Basic Research Program of Sichuan Province (2020YJ0485)
Topics
  • Health Sciences › Medicine › Oncology › Gastric Cancer Management and Outcomes
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gene expression and cancer classification
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › MicroRNA in disease regulation
Keywords
gastric cancer, diagnostic biomarkers, prognostic factors, serum exosomes, gene expression signatures, AGT, HSP47, MMP-7, cell migration, overall survival, non-invasive diagnosis

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: A novel strategy to identify candidate diagnostic and prognostic biomarkers for gastric cancer. https://app.cochat.ai/papers/10.1186/s12935-021-02007-6
The paper
Liu, L., Pang, H., He, Q., Pan, B., Sun, X., Shan, J., Wu, L., Wu, K., Yao, X., & Guo, Y. (2021). A novel strategy to identify candidate diagnostic and prognostic biomarkers for gastric cancer. Cancer Cell International. https://doi.org/10.1186/s12935-021-02007-6

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.